The potential role of imaging techniques in avoiding neck dissection during salvage surgery after head and neck carcinoma treated with bioradiotherapy.


Journal

The Journal of laryngology and otology
ISSN: 1748-5460
Titre abrégé: J Laryngol Otol
Pays: England
ID NLM: 8706896

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 7 9 2021
medline: 21 10 2021
entrez: 6 9 2021
Statut: ppublish

Résumé

This study aimed to evaluate the effectiveness of computed tomography and positron emission tomography-computed tomography prior to salvage surgery after head and neck carcinoma treated with bioradiotherapy and to look at the role of neck dissection in this setting. This study was a retrospective chart review of a series of consecutive patients with locally advanced head and neck squamous cell carcinoma treated with bioradiotherapy. Radiological and pathological stages were compared to evaluate the accuracy of computed tomography and positron emission tomography-computed tomography in detecting occult neck metastasis in the context of recurrence of primary tumour. In order to assess the impact of neck dissection on survival, Kaplan-Meier survival curves after salvage surgery with and without neck dissection were derived. A total of 268 patients were identified, of which 22 underwent salvage surgery. The negative predictive value of computed tomography and positron emission tomography-computed tomography was excellent. Neck dissection did not represent an improvement on overall, disease specific and regional recurrence free survival (p = 0.67, p = 0.91 and p = 0.62, respectively) amongst clinically and radiologically negative necks. Conservative treatment of the neck should be considered when dealing with patients with primary site recurrence or persistent disease after bioradiotherapy without evidence of neck disease.

Identifiants

pubmed: 34482849
doi: 10.1017/S0022215121001900
pii: S0022215121001900
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

970-975

Auteurs

A Rovira (A)

Department of Otorhinolaryngology, Bellvitge University Hospital, Spain.
Faculty of Medicine, Catalan Institute of Oncology, Barcelona, Spain.

J Tornero (J)

Department of Otorhinolaryngology, Bellvitge University Hospital, Spain.

M Taberna (M)

Faculty of Medicine, Catalan Institute of Oncology, Barcelona, Spain.
Department of Medical Oncology, Catalan Institute of Oncology, Barcelona, Spain.

M Oliva (M)

Department of Medical Oncology, Catalan Institute of Oncology, Barcelona, Spain.

R Montal (R)

Department of Medical Oncology, Catalan Institute of Oncology, Barcelona, Spain.

J Nogues (J)

Department of Otorhinolaryngology, Bellvitge University Hospital, Spain.

A Mari (A)

Department of Maxillofacial Surgery, Bellvitge University Hospital, Spain.

J M Viñals (JM)

Department of Plastic and Reconstructive Surgery, Bellvitge University Hospital, Spain.

A Lozano (A)

Department of Radiotherapy, Hospital Duran I Reynalds, Catalan Institute of Oncology, Barcelona,University of Barcelona, Spain.

M Maños (M)

Department of Otorhinolaryngology, Bellvitge University Hospital, Spain.
Faculty of Medicine, Catalan Institute of Oncology, Barcelona, Spain.

R Mesia (R)

Faculty of Medicine, Catalan Institute of Oncology, Barcelona, Spain.
Department of Medical Oncology, Catalan Institute of Oncology, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH